Bertrand C. Liang
Director Técnico/Científico/I+D en PURPLE BIOTECH LTD .
Cargos activos de Bertrand C. Liang
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PURPLE BIOTECH LTD | Director Técnico/Científico/I+D | 09/01/2020 | - |
| Pico Pharmaceuticals, Inc. | Director/Miembro de la Junta | 08/12/2009 | - |
| Asphelia Pharmaceuticals, Inc. | Director/Miembro de la Junta | 08/12/2009 | - |
| Corporate Officer/Principal | - | 08/12/2009 | |
| LCC Ventures | Director/Miembro de la Junta | 08/12/2009 | - |
| Corporate Officer/Principal | - | - | |
Balboa Biosciences, Inc.
 Balboa Biosciences, Inc. BiotechnologyHealth Technology Balboa Biosciences, Inc. operates as a biopharmaceutical company. It develops therapeutics for central nervous system disorders. The company is headquartered in San Diego, CA. | Director/Miembro de la Junta | - | - |
Historial de carrera de Bertrand C. Liang
Antiguos cargos conocidos de Bertrand C. Liang.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PFENEX INC. | Director/Miembro de la Junta | 30/12/2010 | 23/01/2017 |
| Director Ejecutivo | 08/12/2009 | 23/01/2017 | |
| Fundador | 01/12/2009 | 23/01/2017 | |
| Presidente | 01/12/2009 | 23/01/2017 | |
| Secretario Corporativo | 01/12/2009 | 23/01/2017 | |
| LA JOLLA PHARMACEUTICAL COMPANY | Director/Miembro de la Junta | 08/12/2010 | 19/01/2012 |
Paramount BioCapital Asset Management, Inc.
 Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Founded in 1991 by Dr. Lindsay Rosenwald, Paramount BioCapital Asset Management, Inc. is a hedge fund manager located in New York City. The firm is a subsidiary of Paramount BioCapital, Inc. | Gestor de Cartera-Acciones | - | 30/04/2007 |
| University of Vermont | Corporate Officer/Principal | - | - |
| ░░░ ░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ | - | - | |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | - |
Formación de Bertrand C. Liang.
| Boston University | Undergraduate Degree |
| Regis University | Masters Business Admin |
| The University of Bolton | Doctorate Degree |
| Feinberg School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 20 |
| Israel | 3 |
| Japón | 2 |
Operativa
| Director/Board Member | 10 |
| Corporate Officer/Principal | 9 |
| Founder | 3 |
Sectorial
| Health Technology | 11 |
| Consumer Services | 7 |
| Finance | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 6 |
|---|---|
| AMGEN INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| FORTRESS BIOTECH, INC. | Health Technology |
| IDEC CORPORATION | Electronic Technology |
| PURPLE BIOTECH LTD | Health Technology |
| Empresas privadas | 11 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Paramount BioCapital Asset Management, Inc.
Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Founded in 1991 by Dr. Lindsay Rosenwald, Paramount BioCapital Asset Management, Inc. is a hedge fund manager located in New York City. The firm is a subsidiary of Paramount BioCapital, Inc. | Finance |
TRF Pharma, Inc.
 TRF Pharma, Inc. Pharmaceuticals: MajorHealth Technology TRF Pharma, Inc. develops pharmaceutical products. It specializes in the fields of hematology and oncology. The firm's services include developing therapies to treat diseases related to aberrant cell adhesion and endothelial walls. The company was founded by Stephen H. Embury and Neil Matsui in 2002 and is headquartered in Burlingame, CA. | Health Technology |
| Asphelia Pharmaceuticals, Inc. | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Finance |
Balboa Biosciences, Inc.
Balboa Biosciences, Inc. BiotechnologyHealth Technology Balboa Biosciences, Inc. operates as a biopharmaceutical company. It develops therapeutics for central nervous system disorders. The company is headquartered in San Diego, CA. | Health Technology |
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
| LCC Ventures | |
| Pico Pharmaceuticals, Inc. |
- Bolsa de valores
- Insiders
- Bertrand C. Liang
- Experiencia
